Uma Sinha

4.4k total citations · 1 hit paper
109 papers, 2.9k citations indexed

About

Uma Sinha is a scholar working on Hematology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Uma Sinha has authored 109 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Hematology, 31 papers in Molecular Biology and 28 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Uma Sinha's work include Blood Coagulation and Thrombosis Mechanisms (39 papers), Atrial Fibrillation Management and Outcomes (20 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (19 papers). Uma Sinha is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (39 papers), Atrial Fibrillation Management and Outcomes (20 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (19 papers). Uma Sinha collaborates with scholars based in United States, India and Canada. Uma Sinha's co-authors include Stanley J. Hollenbach, David R. Phillips, Francis DeGuzman, Pamela B. Conley, Athiwat Hutchaleelaha, Mayuko Inagaki, Genmin Lu, Mark J. Karbarz, Keith Abe and Peng Luan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Uma Sinha

104 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa

2013 533 citations Genmin Lu, Francis DeGuzman et al. profile →

Peers

Countries citing papers authored by Uma Sinha

Since Specialization

Citations

This map shows the geographic impact of Uma Sinha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uma Sinha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uma Sinha more than expected).

Fields of papers citing papers by Uma Sinha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uma Sinha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uma Sinha. The network helps show where Uma Sinha may publish in the future.

Co-authorship network of co-authors of Uma Sinha

This figure shows the co-authorship network connecting the top 25 collaborators of Uma Sinha. A scholar is included among the top collaborators of Uma Sinha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uma Sinha. Uma Sinha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Acoramidis for Transthyretin Amyloid Cardiomyopathy: Open-Label Extension Study Long-Term Follow-Up 2025 ·Journal of Cardiac Failure ·Ahmad Masri, Mandar A. Aras, (unknown), Daniel Jacoby, Mathew S. Maurer, Sanjiv J. Shah, Ronald Witteles, Paul Wong, Alan X. Ji, (unknown), Suresh Siddhanti, Leonid Katz, Uma Sinha, Jonathan C. Fox, Daniel P. Judge	2
2	ACORAMIDIS IMPROVES SERUM TTR LEVELS IN PATIENTS WITH WILD-TYPE OR VARIANT TRANSTHYRETIN AMYLOID CARDIOMYOPATHY 2025 ·Journal of the American College of Cardiology ·Margot K. Davis, Kevin Alexander, Amrut V. Ambardekar, Daniel P. Judge, (unknown), (unknown), Michel G. Khouri, Richard K. Cheng, Richard F. Wright, Robert Gordon, (unknown), Suresh Siddhanti, (unknown), Jonathan C. Fox, Alan X. Ji, Uma Sinha, Julian D. Gillmore, Mathew S. Maurer	0
3	Long-term Safety And Tolerability Of Acoramidis (AG10) In Symptomatic Transthyretin Amyloid Cardiomyopathy: 4-year Update From An Ongoing, Phase 2, Open-label Extension Study 2024 ·Journal of Cardiac Failure ·Ahmad Masri, Mandar A. Aras, Rodney H. Falk, Martha Grogan, Daniel Jacoby, Matthew J. Maurer, Sanjiv J. Shah, Ronald Witteles, Paul Wong, Alan X. Ji, (unknown), Suresh Siddhanti, Uma Sinha, Jonathan C. Fox, Daniel P. Judge	3
4	LONG-TERM SAFETY AND TOLERABILITY OF ACORAMIDIS (AG10) IN SYMPTOMATIC TRANSTHYRETIN AMYLOID CARDIOMYOPATHY: UPDATED ANALYSIS FROM AN ONGOING PHASE 2 OPEN-LABEL EXTENSION STUDY 2022 ·Journal of the American College of Cardiology ·Ahmad Masri, Mandar A. Aras, Rodney H. Falk, Martha Grogan, Daniel Jacoby, Daniel P. Judge, Sanjiv J. Shah, Ronald Witteles, Alan X. Ji, Paul Wong, Xiaofan Cao, (unknown), Leonid Katz, Uma Sinha, Jonathan C. Fox, Matthew J. Maurer	2
5	Effectiveness of Scapular Mobilization versus Myofascial Release of Subscapularis on Pain, ROM and Function in Subjects with Chronic Frozen Shoulder: A Comparative Study 2019 ·International Journal of Health Sciences and Research ·Uma Sinha, (unknown), (unknown)	4
6	Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy 2019 ·Journal of the American College of Cardiology ·Daniel P. Judge, Stephen B. Heitner, Rodney H. Falk, Matthew J. Maurer, Sanjiv J. Shah, Ronald Witteles, Martha Grogan, Van Selby, Daniel Jacoby, Mazen Hanna, José Nativi-Nicolau, J. Patel, (unknown), Uma Sinha, (unknown), Jonathan C. Fox	180
7	Abstract 13847: Differential Transthyretin Binding, Kinetic Stability and Additive Ex Vivo Stabilization by AG10 Compared to Tafamidis 2019 ·Circulation ·Alan X. Ji, Paul Wong, (unknown), Uma Sinha	1
8	Recurrent hypokalemic paralysis: An atypical presentation of hypothyroidism 2013 ·Indian Journal of Endocrinology and Metabolism ·Uma Sinha, Nilanjan Sengupta, (unknown), (unknown)	11
9	ABSENCE OF QTC PROLONGATION WITH BETRIXABAN: A RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND POSITIVE-CONTROLLED THOROUGH ECG STUDY 2013 ·Journal of the American College of Cardiology ·Uma Sinha, Joel Morganroth, Daniel D. Gretler, Stanley J. Hollenbach, Joseph L. Lambing	1
10	Human immunodeficiency virus endocrinopathy 2011 ·Indian Journal of Endocrinology and Metabolism ·Uma Sinha, Nilanjan Sengupta, P. K. Mukhopadhyay, (unknown)	25
11	Abstract 12420: Reversal of Low Molecular Weight Heparin and Fondaparinux by a Recombinant Antidote (r-Antidote, PRT064445) 2010 ·Circulation ·Genmin Lu, Francis DeGuzman, Stanley J. Hollenbach, Peng Luan, Keith Abe, (unknown), Pamela B. Conley, David R. Phillips, Uma Sinha	8
12	Design, Synthesis and Discovery of 1-(2-(6-Chloro-3-methylsulfonyl)-naphthyl)-1H-pyrazole-5-carboxylamides as Highly Potent Factor Xa Inhibitors 2009 ·Chemical and Pharmaceutical Bulletin ·Zhaozhong J. Jia, Robert M. Scarborough, Penglie Zhang, (unknown), Ann Arfsten, Uma Sinha, Bing‐Yan Zhu	2
13	Parallel synthesis and structure–activity relationships of a series of highly potent, selective, and neutral factor Xa inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Erick A. Goldman, Wenrong Huang, Ting Su, Lingyan Wang, John Woolfrey, Yanhong Wu, (unknown), Ann Arfsten, Brian Huang, (unknown), (unknown), (unknown), Uma Sinha, Paul Wong, Athiwat Hutchaleelaha, Robert M. Scarborough, Bing‐Yan Zhu	7
14	Design, synthesis and structure–Activity relationships of benzoxazinone-Based factor Xa inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Wenrong Huang, Penglie Zhang, (unknown), Lingyan Wang, John Woolfrey, Yonghong Song, Zhaozhong J. Jia, Lane A. Clizbe, Ting Su, (unknown), Brian Huang, Paul Wong, Uma Sinha, Gary Park, (unknown), J Malinowski, Stanley J. Hollenbach, Robert M. Scarborough, Bing‐Yan Zhu	18
15	Design, synthesis, and structure–Activity relationships of substituted piperazinone-Based transition state factor Xa inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Ting Su, Hua Yang, Deborah L. Volkots, John Woolfrey, (unknown), Paul Wong, Uma Sinha, Robert M. Scarborough, Bing‐Yan Zhu	20
16	Substituted acrylamides as factor Xa inhibitors: improving bioavailability by P1 modification 2002 ·Bioorganic & Medicinal Chemistry Letters ·Yonghong Song, Lane A. Clizbe, (unknown), Willy Teng, Wenhao Li, Paul Wong, Brian Huang, Uma Sinha, Gary Park, (unknown), Robert M. Scarborough, Bing‐Yan Zhu	30
17	Design, synthesis and biological activity of novel non-amidine factor Xa inhibitors. Part 1: P1 structure–activity relationships of the substituted 1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides 2002 ·Bioorganic & Medicinal Chemistry Letters ·Zhaozhong J. Jia, Yanhong Wu, Wenrong Huang, Erick A. Goldman, Penglie Zhang, John Woolfrey, Paul Wong, Brian Huang, Uma Sinha, Gary Park, (unknown), Robert M. Scarborough, Bing‐Yan Zhu	16
18	Discovery of Transition State Factor Xa Inhibitors as Potential Anticoagulant Agents 2001 ·Current Topics in Medicinal Chemistry ·Bing‐Yan Zhu, Wenrong Huang, Ting Su, Charles K. Marlowe, Uma Sinha, (unknown), Robert M. Scarborough	8
19	Design, synthesis and structure–activity relationship of a series of arginine aldehyde factor Xa inhibitors. Part 1: structures based on the (d)-Arg-Gly-Arg tripeptide sequence 2000 ·Bioorganic & Medicinal Chemistry Letters ·Charles K. Marlowe, Uma Sinha, (unknown), Robert M. Scarborough	17
20	Two new extracellular serine proteases from Streptomyces fradiae 1991 ·International Journal of Biochemistry ·Uma Sinha, (unknown), Pushkaraj J. Lad	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact